SEASUN THERAPEUTICS has a total of 14 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are INST OF OPHTHALMOLOGY, MIURA NORIMASA and MIRNA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Kim Hye Joo | 14 |
#2 | Park Hee Kyung | 14 |
#3 | Kang Yusun | 8 |
#4 | Yu Ji-Yeon | 8 |
#5 | Lee Dong In | 8 |
#6 | Yu Ji Yeon | 6 |
#7 | Batochir Chinbayar | 5 |
#8 | Hur Deokhwe | 5 |
#9 | Jeo Goonho | 5 |
#10 | Park Min-Jung | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021075880A1 | Peptide-nucleic acid complex having blood-brain barrier penetration ability and composition comprising same | |
WO2020096234A1 | Composition for preventing or treating atopic dermatitis comprising skin-penetrating nucleic acid complex as effective component | |
KR20200090418A | Composition for Preventing or Treating Psoriasis Comprising Skin Permeable Nucleic Acid Complex | |
KR20200090419A | Composition for Treating Disease Concerning vascularization Containing Nucleic Acid Complex | |
KR20190096149A | Skin-penetrating Delivery Carrier Comprising Nucleic Acid Complex and Uses thereof | |
KR20190096148A | Peptide Nucleic Acid Complex with Endosome Escape Ability and Uses thereof | |
AU2017310146A1 | Peptide nucleic acid complex having improved cell permeability and pharmaceutical composition comprising same |